SavedAdd your journal

Journals / Van Sağlık Bilimleri Dergisi / 2020 / Cilt: 13 - Sayı: 1

p38 MAPK ATTENUATES INSULIN SIGNALING BY INHIBITING IRS1 TYROSINE PHOSPHORYLATION IN IRS1 OVEREXPRESSED 293T CELLS

p38 MAPK, IRS1 EKSPRESYONU ARTTIRILMIŞ 293T HÜCRELERİNDE IRS1 TİROZİN FOSFORİLASYONUNU İNHİBE EDEREK İNSÜLİN SİNYALİNİ YAVAŞLATMAKTADIR

Gökhan GÖRGİŞEN
Osman Nidai OZES
Pages
19–24
Publication Date
2020-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: p38 MAPK inhibits the phosphorylations of IRS1, AKT and ERK1/2. p38 MAPK may serve as a therapeutic target for insulin resistance and specific p38 MAPK inhibitors might be potential and promising agents for the therapeutic approaches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the effect of p38 MAPK on insulin signaling in IRS1 overexpressed 293T cells.
📊
Key Findings & Data:Materials and Methods: 293T cells were transfected with pcDNA3.1flag-tagged-human-IRS1 expression vector.
💡
Conclusion & Impact:Conclusion: p38 MAPK inhibits the phosphorylations of IRS1, AKT and ERK1/2. p38 MAPK may serve as a therapeutic target for insulin resistance and specific p38 MAPK inhibitors might be potential and promising agents for the therapeutic approaches.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:p38 MAPK · IRS1 · İnsülin sinyali

Abstract

Objective: The aim of this study was to investigate the effect of p38 MAPK on insulin signaling in IRS1 overexpressed 293T cells. Materials and Methods: 293T cells were transfected with pcDNA3.1flag-tagged-human-IRS1 expression vector. Anisomycin and SB203580 were used as p38 MAPK activator and inhibitor respectively. Expression and phosphorylation profiles of IRS1, AKT and ERK1/2 were detected by western blotting. Results: Anisomycin treatment led to decrease in insulin induced tyrosine phosphorylation of IRS1 through Ser/Thr phosphorylations. We also detected insulin induced AKT and ERK1/2 phosphorylations reduced by anisomycin compared to insulin treated group. We observed that negative effects of anisomycin on insulin signaling reversed by the treatment of SB203580. Conclusion: p38 MAPK inhibits the phosphorylations of IRS1, AKT and ERK1/2. p38 MAPK may serve as a therapeutic target for insulin resistance and specific p38 MAPK inhibitors might be potential and promising agents for the therapeutic approaches.

Özet

Amaç: Bu çalışmanın amacı IRS1 ekspresyonu arttırılmış 293T hücrelerinde p38 MAPK’ ın insülin sinyali üzerindeki etkisinin belirlenmesidir. Materyal Metod: 293T hücreleri pcDNA3.1flag-tagged-insan-IRS1 ekspresyon vektörü ile transfekte edilmiştir. P38 MAPK inhibitörü ve aktivatörü olarak sırasıyla anisomisin ve SB203580 kullanılmıştır. IRS1, AKT ve ERK1/2 ekspresyon ve aktivasyon profilleri western blot ile belirlenmiştir. Bulgular: Anisomisin muamelesi IRS1 Ser/Thr fosforilasyonu aracılığıyla insülin indüklü IRS1 tirozin fosforilasyonunu azalmıştır. Anisomisin muamele grupta kontrol grubuna oranla insülin indüklü AKT ve ERK1/2 fosforilasyonunda da azalma olduğu belirlenmiştir. Anisomisinin insülin sinyali üzerindeki negatif etkilerinin SB203580 muamelesi ile geri döndürüldüğü gözlemlenmiştir. Sonuç: p38 MAPK, IRS1, AKT ve ERK1/2 fosforilasyonlarını inhibe etmektedir. P38 MAPK, insülin direncinde terapötik hedef olarak kullanılabilir ve spesifik p38 MAPK inhibitörleri, terapötik yaklaşımlar için potansiyel ve umut verici ajanlar olabilir.

🔖

Cite This Article

GÖRGİŞEN, G., OZES, O. N. (2020). p38 MAPK ATTENUATES INSULIN SIGNALING BY INHIBITING IRS1 TYROSINE PHOSPHORYLATION IN IRS1 OVEREXPRESSED 293T CELLS. Van Sağlık Bilimleri Dergisi, Cilt: 13 - Sayı: 1, 19–24. https://ajindex.com/articles/821514

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. American journal of physiology. Endocrinology and Metabolism. 2009;296: 581-591.
  2. Cao W, Collins QF, Becker TC, Robidoux J, Lupo EG Jr et al. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem. 2005; 280(52):42731-42737.
  3. Collins QF, Xiong Y, Lupo EG Jr, Liu HY, Cao W. p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J Biol Chem. 2006;281(34):24336-24344.
  4. Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012;55:2565-2582. Cuenda A. p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochimica et Biophysica Acta. 2007;1773:1358-1375.
  5. Fang P, Sun Y, Gu X, Shi M, Bo P et al. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway. Phytomedicine. 2019;64:153074. Feifel E, Obexer P, Andratsch M, Euler S, Taylor L et al. p38 MAPK mediates acid-induced transcription of PEPCK in LLC-PK(1)-FBPase(+) cells. Am. J. Physiol. Renal. Physiol. 2002;283(4):678-688.
  6. Geiger PC, Wright DC, Han D-H, Holloszy JO. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab. 2005;288:782– 788. Gorgisen G, Balci MK, Celik FC, Gokkaya M, Ozdem S et al. Differential activation and expression of IRS1 in mononuclear cells of type 2 diabetes patients after insulin stimulation. Cell Mol Biol (Noisy-le-grand). 2016;62(2):25-30.
  7. Gorgisen G, Gulacar IM, Ozes ON. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation. Cell Mol Biol (Noisy-le-grand). 2017;63(1):1-5. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 2014;220(2):1-23.
  8. Hancer NJ, Qiu W, Cherella C, Li Y, Copps KD et al. Insulin and metabolic stress stimulate multisite serine/ threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. The Journal of Biological Chemistry 2014;289: 12467-12484.
  9. Hemi R, Yochananov Y, Barhod E, Kasher-Meron M, Karasik A et al. p38 Mitogen-activated protein kinase-dependent transactivation of ErbB receptor family a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Di